25 Year C-Suite Natural Food Executive Ali Samei Expands Into Leadership Role At Boosh; Set to Oversee All North American Operations Biotech Investing
Upadacitinib Met the Primary and All Secondary Endpoints in the 52-Week Phase 3 Maintenance Study in Ulcerative Colitis Patients Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo Plus Yervoy for the Treatment of Mismatch Repair Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer After Prior Chemotherapy Biotech Investing
Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-621 in Combination With Doxorubicin in Leiomyosarcoma Biotech Investing
Lexaria Bioscience CEO: Faster, Cost-efficient Drug Delivery Platform for COVID-19 and Beyond Video Interview
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options Biotech Investing
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDT Biotech Investing
AbbVie Gastroenterology Pipeline to be Featured at the 16th Congress of European Crohn's and Colitis Organisation Biotech Investing
Kite Announces Yescarta® CAR T-cell Therapy Improved Event-Free Survival by 60% Over Chemotherapy Plus Stem Cell Transplant in Second-Line Relapsed or Refractory Large B-cell Lymphoma Biotech Investing
